Jun Bao

Title: The Innovative Contributions of Jun Bao

Introduction

Jun Bao is a notable inventor based in Baltimore, MD, who has made significant strides in the field of neuroprotection. His work focuses on developing methods to prevent or treat neurotoxicity, particularly in relation to ischemia and reperfusion injury, as well as neurodegenerative diseases.

Latest Patents

Jun Bao holds a patent for a method of using selective PARP inhibitors to prevent or treat neurotoxicity. This innovative approach involves administering therapeutically effective amounts of certain selective inhibitors of poly(ADP-ribose) polymerase. The inhibitors can be delivered through various methods, including intravenous, intraperitoneal, intramuscular, intraventricular, or oral routes. They can be formulated as capsules or tablets containing single or divided doses, or as sterile solutions, suspensions, or emulsions.

Career Highlights

Jun Bao is affiliated with The Johns Hopkins University, where he contributes to cutting-edge research in neuroprotection. His work has the potential to significantly impact the treatment of conditions that lead to neural damage, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Jun Bao has collaborated with esteemed colleagues, including Mikael J Eliasson and Kenji Sampei. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic strategies.

Conclusion

Jun Bao's contributions to the field of neuroprotection through his patent and research at The Johns Hopkins University highlight his role as a leading inventor. His work not only addresses critical medical challenges but also paves the way for future advancements in treating neurodegenerative diseases.